Clinical Trial: A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07766005) titled 'A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)' on Aug. 10.

Brief Summary: This Phase 2 study will test whether the investigational medicine, SPY072, improves hidradenitis suppurativa (HS) in adults with moderate to severe disease receiving advanced standard of care treatment. About 150 participants will be assigned by chance to receive either SPY072 or placebo for 16 weeks. Participants will be followed after the treatment period to evaluate safety and how long treatment effects may last.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Hidradenitis Suppurati...